Health
Hematopoietic stem cell transplants may provide long-term benefit for people with MS – EurekAlert
A new study shows that intense immunosuppression followed by a hematopoietic stem cell transplant may prevent disability associated with multiple sclerosis (MS)…
MINNEAPOLIS – A new study shows that intense immunosuppression followed by a hematopoietic stem cell transplant may prevent disability associated with multiple sclerosis (MS) from getting worse in 71% of people with relapsing-remitting MS for up to 10 years after the treatment. The research is published in the January 20, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study also found that in some people their disability improved over 10 years after…
-
General21 hours agoMigrants raise concerns over Australia’s English tests for visa applicants
-
Noosa News23 hours agoSunshine Coast women celebrated at 26th annual business awards
-
Noosa News24 hours agoNew FLC President has regional lens – Proctor
-
Noosa News20 hours agoCCTV footage shows stolen ute slamming into fuel bowsers at Kojonup petrol station